Loading...
•
Dec 31, 2020
ResMed Q2 2021 Earnings Report
ResMed's second-quarter results reflected continued solid performance with top-line growth and double-digit improvement in operating income and earnings per share.
Key Takeaways
ResMed Inc. reported a 9% increase in revenue to $800.0 million for the second quarter of fiscal year 2021. GAAP diluted earnings per share were $1.23, and non-GAAP diluted earnings per share were $1.41. The company saw growth in its core markets and adoption of digital health solutions.
Revenue increased by 9% year-over-year to $800.0 million.
GAAP gross margin was 57.8%, while non-GAAP gross margin expanded to 59.9%.
Net operating profit increased by 12%, and non-GAAP operating profit rose by 16%.
GAAP diluted earnings per share reached $1.23, and non-GAAP diluted earnings per share were $1.41.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
No specific forward guidance was provided in the release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...